Osaka, Japan & Lyon, France, aug 07, 2024 – Sumitomo Pharma and Poxel Announce Topline Results from Post-Marketing
Clinical Study on TWYMEEG® for the Treatment of Type 2 Diabetes in Japan
Sumitomo Pharma and Poxel AnnounceTopline Results from Post-MarketingClinical Study on TWYMEEG® for the Treatment of Type 2 Diabetes in Japan